These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35091761)

  • 1. Automated liquid handling robot for rapid lateral flow assay development.
    Anderson CE; Huynh T; Gasperino DJ; Alonzo LF; Cantera JL; Harston SP; Hsieh HV; Marzan R; McGuire SK; Williford JR; Oncina CI; Glukhova VA; Bishop JD; Cate DM; Grant BD; Nichols KP; Weigl BH
    Anal Bioanal Chem; 2022 Mar; 414(8):2607-2618. PubMed ID: 35091761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Antibody Rapid Tests: Valuable Epidemiological Tools in Challenging Settings.
    Saluzzo F; Mantegani P; Poletti De Chaurand V; Quaresima V; Cugnata F; Di Serio C; Macé A; De Vos M; Sacks JA; Cirillo DM
    Microbiol Spectr; 2021 Oct; 9(2):e0025021. PubMed ID: 34549999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated Development of a COVID-19 Lateral Flow Test in an Academic Setting: Lessons Learned.
    Kourentzi K; Brosamer K; Vu B; Willson RC
    Acc Chem Res; 2024 May; 57(9):1372-1383. PubMed ID: 38590049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Commercial Rapid Lateral Flow Tests, Alone or in Combination, for SARS-CoV-2 Antibody Testing.
    Fischer PU; Fischer K; Curtis KC; Huang Y; Fetcho N; Goss CW; Weil GJ
    Am J Trop Med Hyg; 2021 Jun; 105(2):378-386. PubMed ID: 34181574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate binding module-fused antibodies improve the performance of cellulose-based lateral flow immunoassays.
    Elter A; Bock T; Spiehl D; Russo G; Hinz SC; Bitsch S; Baum E; Langhans M; Meckel T; Dörsam E; Kolmar H; Schwall G
    Sci Rep; 2021 Apr; 11(1):7880. PubMed ID: 33846482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune response.
    David A; Scott L; Jugwanth S; Gededzha M; Kahamba T; Zwane N; Mampeule N; Sanne I; Stevens W; Mayne ES
    J Immunol Methods; 2021 Sep; 496():113096. PubMed ID: 34242653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high-throughput microfluidic nanoimmunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultralow-volume blood samples.
    Swank Z; Michielin G; Yip HM; Cohen P; Andrey DO; Vuilleumier N; Kaiser L; Eckerle I; Meyer B; Maerkl SJ
    Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33945500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Coronavirus Nucleocapsid Antigen-Detecting Half-Strip Lateral Flow Assay Toward the Development of Point of Care Tests Using Commercially Available Reagents.
    Grant BD; Anderson CE; Williford JR; Alonzo LF; Glukhova VA; Boyle DS; Weigl BH; Nichols KP
    Anal Chem; 2020 Aug; 92(16):11305-11309. PubMed ID: 32605363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex diagnosis of viral infectious diseases (AIDS, hepatitis C, and hepatitis A) based on point of care lateral flow assay using engineered proteinticles.
    Lee JH; Seo HS; Kwon JH; Kim HT; Kwon KC; Sim SJ; Cha YJ; Lee J
    Biosens Bioelectron; 2015 Jul; 69():213-25. PubMed ID: 25747506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of three point-of-care lateral flow immunoassays for detection of anti-SARS-CoV-2 antibodies: data from 100 healthcare workers in Brazil.
    Conte DD; Carvalho JMA; de Souza Luna LK; Faíco-Filho KS; Perosa AH; Bellei N
    Braz J Microbiol; 2021 Sep; 52(3):1161-1165. PubMed ID: 33871824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A portable and universal upconversion nanoparticle-based lateral flow assay platform for point-of-care testing.
    Gong Y; Zheng Y; Jin B; You M; Wang J; Li X; Lin M; Xu F; Li F
    Talanta; 2019 Aug; 201():126-133. PubMed ID: 31122402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 antigens.
    Baccani I; Morecchiato F; Chilleri C; Cervini C; Gori E; Matarrese D; Bassetti A; Bonizzoli M; Mencarini J; Antonelli A; Rossolini GM
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115434. PubMed ID: 34174523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dye-Loaded Polymersome-Based Lateral Flow Assay: Rational Design of a COVID-19 Testing Platform by Repurposing SARS-CoV-2 Antibody Cocktail and Antigens Obtained from Positive Human Samples.
    Ghorbanizamani F; Tok K; Moulahoum H; Harmanci D; Hanoglu SB; Durmus C; Zihnioglu F; Evran S; Cicek C; Sertoz R; Arda B; Goksel T; Turhan K; Timur S
    ACS Sens; 2021 Aug; 6(8):2988-2997. PubMed ID: 34270230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
    Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
    J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of rapid lateral flow assays from capillary blood specimens to the diagnosis of COVID-19 in symptomatic healthcare workers: a pilot study in a university hospital, Paris, France.
    Charpentier C; Pellissier G; Ichou H; Ferré VM; Larfi I; Phung BC; Vallois D; LeGac S; Aubier M; Descamps D; Fidouh-Houhou N; Bouvet E
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115430. PubMed ID: 34229244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody Screening Results for Anti-Nucleocapsid Antibodies Toward the Development of a Lateral Flow Assay to Detect SARS-CoV-2 Nucleocapsid Protein.
    Cate DM; Bishop JD; Hsieh HV; Glukhova VA; Alonzo LF; Hermansky HG; Barrios-Lopez B; Grant BD; Anderson CE; Spencer E; Kuhn S; Gallagher R; Rivera R; Bennett C; Byrnes SA; Connelly JT; Dewan PK; Boyle DS; Weigl BH; Nichols KP
    ACS Omega; 2021 Oct; 6(39):25116-25123. PubMed ID: 34608447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital.
    Ong DSY; de Man SJ; Lindeboom FA; Koeleman JGM
    Clin Microbiol Infect; 2020 Aug; 26(8):1094.e7-1094.e10. PubMed ID: 32502646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and multi-center clinical trials of an up-converting phosphor technology-based point-of-care (UPT-POCT) assay for rapid COVID-19 diagnosis and prediction of protective effects.
    Zhang P; Li B; Wang Y; Min W; Wang X; Zhou Y; Li Z; Zhao Y; Zhang H; Jiang M; Zheng H; Yang C; Zhang W; Zuo L; Gao Q; Yang Z; Li Y; Feng T; Lin C; Hu Q; Song T; Yang R
    BMC Microbiol; 2022 Feb; 22(1):42. PubMed ID: 35114938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-of-care COVID-19 diagnostics powered by lateral flow assay.
    Zhou Y; Wu Y; Ding L; Huang X; Xiong Y
    Trends Analyt Chem; 2021 Dec; 145():116452. PubMed ID: 34629572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-colour multiplexed lateral flow immunoassay system to differentially detect human malaria species on a single test line.
    Kim J; Cao XE; Finkelstein JL; Cárdenas WB; Erickson D; Mehta S
    Malar J; 2019 Sep; 18(1):313. PubMed ID: 31533756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.